# Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

> **NCT03208660** · — · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 2000 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Fycompa

## Key facts

- **NCT ID:** NCT03208660
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-07
- **Primary completion:** 2019-03-15
- **Final completion:** 2019-03-15
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2019-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03208660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03208660, "Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03208660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*